Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10486295 | Value in Health Regional Issues | 2013 | 11 Pages |
Abstract
Universal infant vaccination with new available pneumococcal vaccines is expected to generate a significant additional impact on reducing the burden of pneumococcal diseases in Hong Kong. PCV-10 vaccination would be potentially a cost-saving strategy compared with PCV-13 vaccination, generating better cost offsets and higher QALY gains.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Kenneth K.C. BSc (Pharm), MPhil, PhD, David Bin PhD, Oleksandr BSc, Emmanuelle MSc, Rodrigo MD, MSc,